The findings represent that the increased mortality associated with increased C-reactive protein levels and prevalence of comorbidities (hypertension, diabetes, etc.)are also in line with other estimates, suggesting that our data are comparable with other populations [30, 31]. This evidence concerns the gene CRP and hypertensive disorder.